… . (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative … Anaptys is a clinical-stage biotechnology company focused on delivering innovative … also discovered multiple therapeutic antibodies licensed to GSK in a financial …

Making good on plans filed in late January, cystic fibrosis-focused Sionna Therapeutics announced expected figures for its IPO on Monday. In an SEC filing, Sionna said it is offering 8,823,529 shares priced between $16 and $18 per share, for a target total …

… announced an exclusive, global license agreement for the development … receive an exclusive global license to develop, manufacture and … is a clinical-stage biotechnology company focused on delivering … discovered multiple therapeutic antibodies licensed to GSK in …

… growth, driven by advancements in biotechnology and life sciences. The increasing … ;www.emergenresearch.com/select-license/;3492 Latest Published Reports …

… Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive … records covering pharmaceutical and biotechnology The leading regenerative medicine … Most active regenerative medicine licensing dealmakers Analyzing contract agreements …

… also found that young biotechs drew interest from international … a pretty penny on licensing deals last year to … perspective, however, U.K. biotech has demonstrated notable resilience,” the … five years, U.K. biotech stocks have consistently outperformed …

Licensing deals struck by Chinese biotech start-ups with overseas partners … , on so-called asset out-licensing or business development,” Zhang Jialin … regulators for marketing approval. Out-licensing typically involves a drug discoverer …

… the Guggenheim Securities SMID Cap Biotech conference this February. Guggenheim Securities … SMID Cap Biotech Conference, New York, NY … the accuracy, content, images, videos, licenses, completeness, legality, or reliability of …

… at the Guggenheim SMID Cap Biotech Conference in New York on … -free protein synthesis platform, exclusively licensed from Sutro Biopharma, Inc. Unlike …

… backdrop, investing in fundamentally stable biotech stocks, Vertex Pharmaceuticals Incorporated (VRTX … sector’s expansion. The biotechnology industry is experiencing considerable growth … announced an exclusive collaboration and license agreement with Zai Lab …